A COST-EFFECTIVENESS ANA LYSIS OF ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASES AND COLORECTAL CANCER

被引：2
|
作者：
Soon, S. [1 ]
Chia, W. J. [2 ]
Redekop, K. [3 ]
Wee, H. L. [1 ]
机构：
[1] Natl Univ Singapore, Singapore, Singapore
[2] Natl Canc Ctr Singapore, Singapore, Singapore
[3] Erasmus Univ, Inst Med Technol Assessment, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1200
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN183
引用
收藏
页码：A462 / A462
页数：1
相关论文
共 50 条
  • [21] Primary prevention of cardiovascular disease: A cost-effectiveness comparison
    Franco, OH
    De Laet, C
    Kinderen, AD
    Peeters, A
    Bonneux, L
    CIRCULATION, 2004, 110 (17) : 802 - 802
  • [22] Cost-effectiveness of antihypertensives in the primary prevention of cardiovascular disease
    Duran, O. H. Franco
    Kinderen, A. Der
    Steyerberg, E.
    EUROPEAN HEART JOURNAL, 2006, 27 : 578 - 578
  • [23] THE COST-EFFECTIVENESS ANA LYSIS FOR HIV TREATMENT ALTERNATIVES IN TURKEY
    Kockaya, G.
    Yenilmez, F. B.
    Zengin, Elbir T.
    Dalgic, C.
    Malhan, S.
    Cerci, P.
    Oksuz, E.
    Tayfun, K.
    Unal, S.
    VALUE IN HEALTH, 2014, 17 (07) : A678 - A678
  • [24] Cost-Effectiveness of Aspirin, Celecoxib, and Calcium Chemoprevention for Colorectal Cancer
    Squires, Hazel
    Tappenden, Paul
    Cooper, Katy
    Carroll, Christopher
    Logan, Richard
    Hind, Daniel
    CLINICAL THERAPEUTICS, 2011, 33 (09) : 1289 - 1305
  • [25] Prevention of cardiovascular diseases in Nairobi slums: a cost-effectiveness study
    van de Vijver, Steven
    Oti, Samuel
    Gomez, Gabriela B.
    Agyemang, Charles
    Lange, Joep
    Kyobutungi, Catherine
    LANCET, 2014, 384 : S12 - S12
  • [26] Costs and cost-effectiveness of colorectal cancer prevention and therapy
    Schrag, D
    Weeks, J
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 561 - 568
  • [27] Aspirin for the primary prevention of cardiovascular diseases
    Tagliabue, Ludovica
    Dipaola, Franca
    Perego, Francesca
    Podda, Gian Marco
    INTERNAL AND EMERGENCY MEDICINE, 2012, 7 (04) : 375 - 379
  • [28] Aspirin for the primary prevention of cardiovascular diseases
    Ludovica Tagliabue
    Franca Dipaola
    Francesca Perego
    Gian Marco Podda
    Internal and Emergency Medicine, 2012, 7 : 375 - 379
  • [29] Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer
    McNellis, Robert J.
    Beswick-Escanlar, Vincent
    AMERICAN FAMILY PHYSICIAN, 2016, 94 (08) : 661 - 662
  • [30] Cost-effectiveness analysis of rivaroxaban plus aspirin versus aspirin alone in secondary prevention among patients with chronic cardiovascular diseases
    Mei-Chuan Lee
    Chia-Te Liao
    Han Siong Toh
    Chih-Chen Chou
    Wei-Ting Chang
    Zhih-Cherng Chen
    Wen-Shiann Wu
    Tsung Yu
    Carol Strong
    Cardiovascular Drugs and Therapy, 2021, 35 : 539 - 547
12345